StocksRunner logo
mail
search
 
menu
 
ADMA Biologics
19.88
-2.79%
 
  Overview  
  
  Analysis  
  
     Risks     
  
  Rating  
  
     Chart     
  
  Analysts  
  
  Street  
  
  Sentiment  
  
  Earnings  
  
  Headlines  
 
 
 
 

ADMA

 

ADMA Biologics

$19.88

 
-$0.57 | -2.79%
 
  Overview  
  
  Analysis  
  
     Risks     
  
  Rating  
  
     Chart     
  
  Analysts  
  
  Street  
  
  Sentiment  
  
  Earnings  
  
  Headlines  
 
 
52W High
$ 25.67
 
 
MKT CAP
$ 4.75B
 
52W Low
$ 8.75
 
 
VOL
$ 3.92M
 
P/E Ratio
23.66
 
 
AVG VOL
$ 4.18M
 
RSI
43.03
 
 
TREND
Sideways
 
 
 

Chart

 
 

20.23

16.07

17.97

9.43

 
 
1year
6month
3month
1month
 
ADMA Latest Headlines +
 
 
 
StocksRunner

Explore our ADMA Stock insights

  • In-Depth Market Analysis and Trends
  • Expert Insights on Market Dynamics
  • Tailored ADMA Stock Strategies
  • Effective Risk Management
 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss
 

Receive our ADMA Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

 
Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

 
Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

 
Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

 
About StocksRunner

Log In

Sign Up

Plans & Pricing

Contact Us

Terms of use

Privacy Policy

 
 
StocksRunner
 
 
StocksRunner
Overview
 
StocksRunner
Trending
 
StocksRunner
Screener
 
StocksRunner
Ideas
 
StocksRunner
Top Rated
 
StocksRunner
Momentum
 
StocksRunner
Earnings
 
Top Banner
 
  Overview  
  
  Analysis  
  
   Risks   
  
  Rating  
  
  Chart  
  
  Analysts  
  
  Street  
  
  Sentiment  
  
  Earnings  
 
 
 
 
 
 

ADMA

 

ADMA Biologics

$19.88

 
-$0.57 | -2.79%
 

 

Chart

 
 

20.23

16.07

17.97

9.43

 
 
1year
6month
3month
1month
 
 
 
 

ADMA Latest Headlines

 
 
 

ADMA Biologics: Ready For More Growth Despite Q1 Earnings Miss.

 

Fri May 9, 2025

 
Earnings

ADMAs Q1 Earnings and Revenues Miss: Buy Sell or Hold the Stock?. ADMA Biologics misses on Q1 earnings and revenues. Nonetheless the growth prospects remain strong as the company raises its revenue guidance for 2025. We recommend the stock to prospective investors.

 

Thu May 8, 2025

 
Earnings
Potential

Why IBD 50s No. 2 Stock ADMA Biologics Just Plummeted By Double Digits.

 

Thu May 8, 2025

 
Momentum

ADMA Biologics Earnings Preview. ADMA Biologics (NASDAQ:) will release its quarterly earnings report on Wednesday 2025-05-07. Here'.s a brief overview for investors ahead of the announcement.Analysts anticipate ADMA Biologics to report an The announcement from ADMA Biologics is eagerly anticipated with investors seeking news of surpassing estimates and favorable guidance for the next quarter.It'.s worth noting for new investors that guidance can be a key determinant of stock price moveme

 

Tue May 6, 2025

 
Earnings
Potential

Should ADMA Biologics Stock Be in Your Portfolio Pre-Q1 Earnings?. Strong performance of Asceniv continues to boost ADMA. We recommend the stock to investors due to its solid long-term fundamentals.

 

Thu May 1, 2025

 
Earnings

Noteworthy Monday Option Activity: ADMA MAR HUM. Looking at options trading activity among components of the Russell 3000 index there is noteworthy activity today in ADMA Biologics Inc (Symbol: ADMA) where a total volume of 18263 contracts has been traded thus far today a contract volume which is representative of approxim

 

Mon Apr 28, 2025

 
Momentum

 
 
 
 
 
StocksRunner

Discover ADMA Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of ADMA. We're here to help you make informed investment decisions today.

 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss

 

Receive our ADMA Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

 
Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

ADMA Stock trends

ADMA Stock performance

ADMA Stock analysis

ADMA investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner ideas

Financial Reports

 
 

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
 
StocksRunner logo
 
Post ×
 
0/666
joker
 
 
 
 
StocksRunner logo
 

Don't Be a Sheep, Be a StocksRunner

 

StocksRunner Aggregates The Most Important Headlines Into A Single Credibility Score

 
StocksRunner thumbnail
 
 

Sign up for free and

continue analysing ADMA

 
Signup to Stocksrunner
 

Already a Member? Click here to Login

 

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

 
 
StocksRunner logo
 

Don't Be a Sheep, Be a StocksRunner

 

StocksRunner Aggregates The Most Important Headlines Into A Single Credibility Score

 
StocksRunner thumbnail
 
 

Sign up for free and

continue analysing ADMA

 
Signup to Stocksrunner
 

Already a Member? Click here to Login

 

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.